Cite

    Qin, L. et al. (2022). A novel long-term intravenous combined with local treatment with human amnion-derived mesenchymal stem cells for a multidisciplinary rescued uremic calciphylaxis patient and the underlying mechanism. Journal of molecular cell biology. p. . [Online].